CROI 2016 Program at a Glance

Program and Agenda

530 Liver Stiffness Predicts Variceal Bleeding in HIV/HCV-Coinfected Patients

537 Primary Care Provider Interest in Treating HCV: A Mixed-Methods Study Oluwaseun Falade-Nwulia 1 ; Ayesha McAdams-Mahmoud 1 ; Risha irvin 1 ; Alex Niculescu 1 ; Kathleen Page 1 ; Carl Latkin 1 ; Monica Mix 1 ; David L.Thomas 2 ; Mark Sulkowski 1 ; Shruti H. Mehta 1 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 JohnsHopkinsUnivSchof Med,Baltimore,MD,USA 538LB High Efficacy of HCV Treatment by Primary Care Providers: The ASCEND Study Sarah M. Kattakuzhy 1 ; Chloe Gross 2 ; GebeyehuTeferi 3 ;Veronica Jenkins 4 ; Benjamin Emmanuel 5 ; Henry Masur 6 ; Shyam Kottilil 7 ; for the ASCEND Investigators 1 InstofHumanVirologyatUnivofMaryland,Bethesda,MD,USA; 2 Inst ofHumanVirology,Bethesda,MD,USA; 3 UnityHlthCare,Washington, DC,USA; 4 Family&MedCounselingServices,Washington,DC,USA; 5 Univ ofMaryland,Baltimore,MD,USA; 6 NIH,Bethesda,MD,USA; 7 Univof MarylandMedCntr,Baltimore,MD,USA 539LB Effect of Baseline Resistance-Associated Variants on SVRWith the 3D Regimen Plus RBV Mark Sulkowski 1 ; Preethi Krishnan 2 ; RakeshTripathi 2 ; Gretja Schnell 2 ; Yan Xie 2 ; Daniel Cohen 2 ; RogerTrinh 3 ; Nancy S. Shulman 3 ;Tami Pilot- Matias 2 ; Christine Collins 2 1 The JohnsHopkinsUniv,Baltimore,MD,USA; 2 AbbVie,NorthChicago, IL, USA; 3 AbbVie Inc,NorthChicago, IL,USA 2:45 PM-4:00 PM HCV Transmission Tracking and Transmission Risks 540 HCV IgG Antibody Avidity as a Biomarker to Estimate Population-Level Incidence Eshan U. Patel 1 ; Andrea L. Cox 2 ; Shruti H. Mehta 3 ; Denali Boon 3 ; Andrew D. Redd 4 ;William Osburn 2 ; Gregory D. Kirk 3 ; David L.Thomas 2 ; Thomas C. Quinn 2 ; Oliver Laeyendecker 1 1 NIH,Bethesda,MD,USA; 2 JohnsHopkinsUnivSchofMed,Baltimore, MD,USA; 3 JohnsHopkinsUniv,Baltimore,MD,USA; 4 NIAID,NIH, Bethesda,MD,USA 541 HCV Phylogenetic Analysis Complements HIV Contact Tracing in an HIV Outbreak Setting Romeo R. Galang 1 ; Jessica Gentry 2 ; Sumathi Ramachandran 1 ; Kathleen A. Backfish 2 ; Sara J. Blosser 2 ; Anupama Shankar 1 ; Pamela Pontones 2 ;William Switzer 1 ; Philip Peters 1 ;Yury Khudyakov 1 1 CDC,Atlanta,GA,USA; 2 IndianaStateDeptofHlth, Indianapolis, IN,USA 542 Limited Overlap in Transmission Clusters of HIV and HCV Among MSM in the Netherlands JoostW.Vanhommerig 1 ; Daniela Bezemer 2 ; Ard van Sighem 2 ; Colette Smit 2 ; JanT. van der Meer 3 ; Bart J. Rijnders 4 ; Joop E. Arends 5 ; Maria Prins 1 ;Thijs J. van de Laar 6 ; Janke Schinkel 7 ; for the observational ATHENA and MOSAIC cohort studies 1 PHServiceofAmsterdam,Amsterdam,Netherlands; 2 StichtingHIV Monitoring,Amsterdam,Netherlands; 3 Cntrof InfectiousDiseasesand ImmunologyAmsterdam,AcademicMedCntr,Amsterdam,Netherlands; 4 ErasmusUnivMedCntr,Rotterdam,Netherlands; 5 UnivMedCntr Utrecht,Utrecht,Netherlands; 6 SanquinBloodSupplyFndn,Amsterdam, Netherlands; 7 AcademicMedCntr,Amsterdam,Netherlands Session P-N3 Poster Abstracts Hall A/B

Nicolás Merchante 1 ; Antonio Rivero-Juárez 2 ; FranciscoTéllez 3 ; Dolores Merino 4 ; María José Ríos 5 ; Guillermo Ojeda-Burgos 6 ; Mohamed Omar Mohamed-Balghata 7 ; Juan Macías 1 ; Antonio Rivero 8 ; Juan A. Pineda 1 ; for the HEPAVIR-cirrhosis study group 1 HospUniversitariodeValme,Sevilla,Spain; 2 IMIBIC,Córdoba,Spain; 3 HospLaLíneade laConcepción (AGSCampodeGibraltar),LaLíneade la Concepción,Spain; 4 ComplejoHospariodeHuelva,Huelva,Spain; 5 Hosp UniversitarioVirgende laMacarena,Seville,Spain; 6 HospUniversitario Virgende laVictoria,Málaga,Spain; 7 ComplejoHospariode Jaén, Jaén, Spain; 8 HospUniversitarioReinaSofía,Córdoba,Spain 2:45 PM-4:00 PM HCV Cure: Moving the Needle from the Patient to the Population 531 Hepatitis C Screening and Linkage to Care at a Comprehensive Health System Kassem Bourgi 1 ; Indira Brar 2 ; Kimberly Baker-Genaw 2 1 HenryFordHosp/WayneStateUniv,Troy,MI,USA; 2 HenryFordHosp/ WayneStateUniv,Detroit,MI,USA 532 Influence of Hepatitis C Virus Screening on Emergency Department Length of Stay Douglas A.White 1 ; Erik S. Anderson 2 ; Sarah K. Pfeil 1 ;Tamara Todorovich 1 ; Laura J. Deering 1 ;Tarak K.Trivedi 1 1 HighlandHosp,AlamedaHlthSystem,Oakland,CA,USA; 2 StanfordUniv, Stanford,CA,USA 533 Devising a Strategy to Control the HCV Epidemic in British Columbia, Canada Ignacio Rozada ; Julio Montaner; MarkW. Hull;Viviane D. Lima BritishColumbiaCntr forExcellence inHIV/AIDS,Vancouver,BC,Canada 534 Project INSPIRE: A Comprehensive Care Coordination Program for HCV Infection Fabienne Laraque 1 ; Marie P. Bresnahan 2 ; Mary Ford 3 ; Payal Desai 2 ; Eric Rude 4 ; Shuchin Shukla 5 ; JeffreyWeiss 6 ; Ponni Perumalswami 6 ; Alain Litwin 5 ; for the Project INSPIRE ImplementationTeam 1 NewYorkCityDHMH,Queens,NY,USA; 2 NewYorkCityDHMH,Long IslandCity,NY,USA; 3 NewYorkCityDHMH,NewYorkCity,NY,USA; 4 New YorkCityDHMH,Queens,NY,USA; 5 MontefioreMedCntr,Bronx,NY,USA; 6 MountSinaiHosp,NewYork,NY,USA 535 HCV Treatment As PreventionWill Require Massive Scale-up to See Prevention Benefits Luis Mier-y-Teran-Romero 1 ; Derek A. Cummings 2 ; David L.Thomas 3 ; Carl Latkin 1 ; John B.Wong 4 ; Gregory D. Kirk 1 ; Shruti H. Mehta 1 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 UnivofFlorida,Gainesville, FL,USA; 3 JohnsHopkinsUnivSchofMed,Baltimore,MD,USA; 4 TuftsUniv, Boston,MA,USA 536 Is HCV Elimination Possible? A Modeling Study of HIV-Positive MSM Sebastiaan J. Hullegie 1 ; Brooke E. Nichols 1 ; Bart J. Rijnders 1 ; Robert J. de Knegt 1 ; Jürgen K. Rockstroh 2 ; Charles A. Boucher 1 ; David A. van deVijver 1 1 ErasmusUnivMedCntr,Rotterdam,Netherlands; 2 Medizinische Univsklinik,Bonn,Germany Session P-N2 Poster Abstracts Hall A/B

Poster Listings

63

CROI 2016